China is developing several second generation vaccines using either inactivated vaccine technology, mRNA or protein subunit technologies. Photo: AFP
China is developing several second generation vaccines using either inactivated vaccine technology, mRNA or protein subunit technologies. Photo: AFP

Coronavirus: China seeks to develop next-gen vaccines amid trial complications

  • Vaccine makers the world over face the dilemma of whether to give a placebo to trial participants when they could be protected by a licensed Covid-19 vaccine
  • Comparing vaccines by independent bodies is hindered by nationalism and company interests

Topic |   Coronavirus pandemic
China is developing several second generation vaccines using either inactivated vaccine technology, mRNA or protein subunit technologies. Photo: AFP
China is developing several second generation vaccines using either inactivated vaccine technology, mRNA or protein subunit technologies. Photo: AFP
READ FULL ARTICLE